103 related articles for article (PubMed ID: 8571178)
21. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
22. Markov model and markers of small cell lung cancer: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis.
Boher JM; Pujol JL; Grenier J; Daurès JP
Br J Cancer; 1999 Mar; 79(9-10):1419-27. PubMed ID: 10188885
[TBL] [Abstract][Full Text] [Related]
23. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer.
Hotta K; Segawa Y; Takigawa N; Kishino D; Saeki H; Nakata M; Mandai K; Eguchi K
Anticancer Res; 2000; 20(3B):2177-80. PubMed ID: 10928173
[TBL] [Abstract][Full Text] [Related]
25. Mental state as a possible independent prognostic variable for survival in patients with advanced lung carcinoma.
Nakahara Y; Mochizuki Y; Miyamoto Y; Tanaka A; Kawamura T; Sasaki S; Nakahara Y; Katsura Y
Cancer; 2002 Jun; 94(11):3006-15. PubMed ID: 12115391
[TBL] [Abstract][Full Text] [Related]
26. Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors.
Jacot W; Quantin X; Boher JM; Andre F; Moreau L; Gainet M; Depierre A; Quoix E; Chevalier TL; Pujol JL;
Br J Cancer; 2001 Apr; 84(7):903-9. PubMed ID: 11286469
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
[TBL] [Abstract][Full Text] [Related]
28. Tumor volume is a better prognostic factor than greatest tumor diameter in stage Ia non-small cell lung cancer.
Tsai CH; Lin CM; Hsieh CC; Hsu WH; Wang HW; Wang LS
Thorac Cardiovasc Surg; 2006 Dec; 54(8):537-43. PubMed ID: 17151969
[TBL] [Abstract][Full Text] [Related]
29. Effects of prognostic factors and treatment on survival in advanced non-small cell lung cancer.
Cağlayan B; Fidan A; Salepçi B; Kiral N; Torun E; Salepçi T; Mayadağli A
Tuberk Toraks; 2004; 52(4):323-32. PubMed ID: 15558354
[TBL] [Abstract][Full Text] [Related]
30. Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer.
Ardizzoni A; Cafferata MA; Tiseo M; Filiberti R; Marroni P; Grossi F; Paganuzzi M
Cancer; 2006 Dec; 107(12):2842-9. PubMed ID: 17103443
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the treatment of non-small cell lung cancer with brain metastasis and the role of risk score as a survival predictor.
Iwasaki A; Shirakusa T; Yoshinaga Y; Enatsu S; Yamamoto M
Eur J Cardiothorac Surg; 2004 Sep; 26(3):488-93. PubMed ID: 15302040
[TBL] [Abstract][Full Text] [Related]
32. Preoperative CYFRA 21-1 levels as a prognostic factor in c-stage I non-small cell lung cancer.
Suzuki H; Ishikawa S; Satoh H; Ishikawa H; Sakai M; Yamamoto T; Onizuka M; Sakakibara Y
Eur J Cardiothorac Surg; 2007 Oct; 32(4):648-52. PubMed ID: 17707649
[TBL] [Abstract][Full Text] [Related]
33. CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation: an independent prognostic factor.
Chen TF; Jiang GL; Fu XL; Wang LJ; Qian H; Wu KL; Zhao S
Lung Cancer; 2007 Apr; 56(1):105-14. PubMed ID: 17166620
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559
[TBL] [Abstract][Full Text] [Related]
35. [Prognostic value of serum CA125 level in patients with advanced non-small cell lung cancer].
Hu Y; Zhong A; Yang X
Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):30-1. PubMed ID: 11776591
[TBL] [Abstract][Full Text] [Related]
36. Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer.
Takeda S; Fukai S; Komatsu H; Nemoto E; Nakamura K; Murakami M;
Ann Thorac Surg; 2005 Apr; 79(4):1142-6. PubMed ID: 15797041
[TBL] [Abstract][Full Text] [Related]
37. [Pre-therapeutic prognostic factors of survival in small cell bronchial cancer. Retrospective study in a series of 112 patients].
Quoix E; Hedelin G; Seibert R; Popin E; Dietemann A; Roeslin N; Pauli G
Rev Mal Respir; 1993; 10(1):29-34. PubMed ID: 8383869
[TBL] [Abstract][Full Text] [Related]
38. [The indications for the curative radiotherapy of non-small-cell bronchial carcinoma. Reflections from a clinical viewpoint].
Bohndorf W; Kiricuta C; Willner J
Strahlenther Onkol; 1994 Sep; 170(9):507-15. PubMed ID: 7940123
[TBL] [Abstract][Full Text] [Related]
39. [The "neuron-specific enolase" tumor marker as a prognostic indicator in small cell bronchial carcinoma].
Hoster M; Kirchheiner T; Rühle KH
Pneumologie; 1995 Aug; 49(8):470-4. PubMed ID: 7479642
[TBL] [Abstract][Full Text] [Related]
40. Estimation of prognosis by circulating biomarkers in patients with non-small cell lung cancer.
Holdenrieder S; Nagel D; Stieber P
Cancer Biomark; 2010; 6(3-4):179-90. PubMed ID: 20660963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
